JENNIFER OWEN: Open Payments
NPI 1982756052 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 49 payments from 15 companies in 2025. Trend: 2023 $600 · 2024 $906 · 2025 $1,082
Food & beverage: $974Education: $108
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $190 |
| Amgen Inc. | 6 | $139 |
| Regeneron Healthcare Solutions, Inc. | 4 | $137 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $88 |
| Ionis Pharmaceuticals, Inc. | 3 | $84 |
| GENZYME CORPORATION | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| CSL Behring | 2 | $42 |
| Lilly USA, LLC | 2 | $40 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, NEFFY, TRELEGY ELLIPTA, DAWNZERA, FASENRA, XOLAIR.
Industry payments across CA — which companies pay providers there.
